Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9561b935203576387ef918805adb4ade http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f65ff6949948806ab6adb4f1b7b69a06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_04ce3104adb2b1121355852178fe8f67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6d6b0a9721d7b7ca7d5f368df0f3658 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f740e250f65b616a6ac714c7d145040 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74f091970969cf2d252ed9bbb6c2d627 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f772e16126dbf9d9555561e9f27afa4 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6876 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2011-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90043eb2b256942b7bd0419702758413 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b780c8314a77853283500d6584e63ebb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca8dfaa3dcae9388bcd9e0c5dff0e196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d5c9b62efb21d0c55ab592a5c22e542 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bf21c97c90766d03ef02547e0b241b2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_310b66e806ef45deb73a943693a882c9 |
publicationDate |
2013-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2013157952-A1 |
titleOfInvention |
Genomic markers for prediction of long-term response to growth hormone (gh) therapy |
abstract |
The present invention relates to the use of genetic markers to identify the response to growth hormone treatment in Growth Hormone Deficiency (GHD) or Turner Syndrome (TS) patients as well as a method of treating GHD or TS patients and kits for genotyping. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9206480-B2 |
priorityDate |
2010-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |